Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73740397)
Watch
English
Thiazolidinediones
scientific article published on 01 September 1997
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9314015
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314015%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
Thiazolidinediones
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9314015
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314015%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
author name string
R R Henry
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9314015
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314015%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
publication date
1 September 1997
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9314015
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314015%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
published in
Endocrinology and Metabolism Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9314015
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314015%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
volume
26
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9314015
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314015%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9314015
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314015%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
page(s)
553-573
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9314015
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314015%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
cites work
Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro studies on the action of CS-045, a new antidiabetic agent
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pathogenesis of NIDDM. A balanced overview
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lack of effect of CS-045, a new antidiabetic agent, on insulin secretion in the remnant pancreas after 90% pancreatectomy in rats
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute effects of troglitazone on in vivo insulin action in normal rats
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of oxidation of low density lipoprotein by troglitazone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Banting lecture 1988. Role of insulin resistance in human disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-performance frontal analysis for the study of protein binding of troglitazone (CS-045) in albumin solution and in human plasma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased insulin responsiveness after CS-045 treatment in diabetes associated with Werner's syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thiazolidinediones (AD-4833 and CS-045) improve hepatic insulin resistance in streptozotocin-induced diabetic rats.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies on hindered phenols and analogues. V. Synthesis, identification, and antidiabetic activity of the glucuronide of CS-045
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antihypertensive effects of CS-045 treatment in obese Zucker rats.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970267-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0889-8529(05)70267-X
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9314015
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314015%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
PubMed publication ID
9314015
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9314015
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9314015%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit